دورية أكاديمية
Adjuvant Gemcitabine Versus Neoadjuvant/Adjuvant FOLFIRINOX in Resectable Pancreatic Cancer: The Randomized Multicenter Phase II NEPAFOX Trial
| العنوان: | Adjuvant Gemcitabine Versus Neoadjuvant/Adjuvant FOLFIRINOX in Resectable Pancreatic Cancer: The Randomized Multicenter Phase II NEPAFOX Trial |
|---|---|
| المؤلفون: | Goetze, Thorsten O.Aff1, Aff2, Aff3, IDs10434024150117_cor1, Reichart, Alexander, Bankstahl, Ulli S., Pauligk, Claudia, Loose, Maria, Kraus, Thomas W., Elshafei, Moustafa, Bechstein, Wolf O., Trojan, Jörg, Behrend, Matthias, Homann, Nils, Venerito, Marino, Bohle, WolframAff10, Aff11, Varvenne, Michael, Bolling, Claus, Behringer, Dirk M., Kratz-Albers, Karsten, Siegler, Gabriele M., Hozaeel, Wael, Al-Batran, Salah-EddinAff1, Aff2, Aff3 |
| المصدر: | Annals of Surgical Oncology. 31(6):4073-4083 |
| قاعدة البيانات: | Springer Nature Journals |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 10689265 15344681 |
|---|---|
| DOI: | 10.1245/s10434-024-15011-7 |